Clinical Trial Update: TNP-2092 to Treat Acute Bacterial Skin and Skin Structure Infection [Phase 2]

View source ↗

Summary

Phase 2 trial update for TNP-2092 in acute bacterial skin and skin structure infections has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gram-positive Bacterial Infections
• Skin and Subcutaneous Tissue Bacterial Infections

Drugs mentioned

• TNP-2092

Snippet

Sponsor: TenNor Therapeutics Limited | Conditions: Skin and Subcutaneous Tissue Bacterial Infections, Gram-Positive Bacterial Infections | Phase 2 | Status: COMPLETED | Results posted: 2023-12-01